These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35872216)

  • 81. Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19.
    Hammerman A; Sergienko R; Friger M; Beckenstein T; Peretz A; Netzer D; Yaron S; Arbel R
    N Engl J Med; 2022 Mar; 386(13):1221-1229. PubMed ID: 35172072
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021.
    Shimabukuro T
    Am J Transplant; 2021 Mar; 21(3):1326-1331. PubMed ID: 33641268
    [No Abstract]   [Full Text] [Related]  

  • 83. Administration of BNT162b2 mRNA COVID-19 vaccine to subjects with various allergic backgrounds.
    Ribak Y; Rubin L; Talmon A; Dranitzki Z; Shamriz O; Hershkowitz I; Tal Y; Hershko AY
    Front Immunol; 2023; 14():1172896. PubMed ID: 37654487
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: The McGill University Health Centre experience.
    ALMuhizi F; Fein M; Gabrielli S; Gilbert L; Tsoukas C; Ben-Shoshan M; Copaescu AM; Isabwe GAC
    Ann Allergy Asthma Immunol; 2022 Aug; 129(2):182-188.e1. PubMed ID: 35609744
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Allergic reactions to COVID-19 vaccines: evidence and practice-oriented approach].
    Klimek L; Eckrich J; Hagemann J; Casper I; Huppertz J
    Internist (Berl); 2021 Mar; 62(3):326-332. PubMed ID: 33580823
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions].
    Özden Ş; Tepetam FM; Atik Ö
    Tuberk Toraks; 2023 Jun; 71(2):166-175. PubMed ID: 37345399
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.
    Greenhawt M; Dribin TE; Abrams EM; Shaker M; Chu DK; Golden DBK; Akin C; Anagnostou A; ALMuhizi F; Alqurashi W; Arkwright P; Baldwin JL; Banerji A; Bégin P; Ben-Shoshan M; Bernstein J; Bingemann TA; Bindslev-Jensen C; Blumenthal K; Byrne A; Cahill J; Cameron S; Campbell D; Campbell R; Cavender M; Chan ES; Chinthrajah S; Comberiati P; Eastman JJ; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Garvey LH; Grayson MH; Isabwe GAC; Hartog N; Hendron D; Horner CC; Hourihane JO; Iglesia E; Kan M; Kaplan B; Katelaris CH; Kim H; Kelso JM; Khan DA; Lang D; Ledford D; Levin M; Lieberman JA; Loh R; Mack DP; Mazer B; Mody K; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Nathan R; Oppenheimer J; Otani IM; Park M; Pawankar R; Perrett KP; Peter J; Phillips EJ; Picard M; Pitlick M; Ramsey A; Rasmussen TH; Rathkopf MM; Reddy H; Robertson K; Rodriguez Del Rio P; Sample S; Sheshadri A; Sheik J; Sindher SB; Spergel JM; Stone CA; Stukus D; Tang MLK; Tracy JM; Turner PJ; Vander Leek TK; Wallace DV; Wang J; Wasserman S; Weldon D; Wolfson AR; Worm M; Yacoub MR
    J Allergy Clin Immunol; 2023 Aug; 152(2):309-325. PubMed ID: 37295474
    [TBL] [Abstract][Full Text] [Related]  

  • 88. How many lives do COVID vaccines save? Evidence from Israel.
    Arbel R; Moore CM; Sergienko R; Pliskin J
    Am J Infect Control; 2022 Mar; 50(3):258-261. PubMed ID: 34971714
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Experiencia en la vacunación frente a la COVID-19 en personas con antecedentes de alergia.].
    García Vicente JA; Vedia Urgell C; Vallès Fernández R; Morgado Ramos C; Moral Roldán E; Marchal Torralbo S; Lladó Blanch M; Marchal Torralbo A; Vértiz Guidotti T; Sorribes López J
    Rev Esp Salud Publica; 2023 Oct; 97():. PubMed ID: 37970964
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Efficacy and safety of an e-consult program for COVID-19 vaccine allergy concerns.
    Kaddis T; Joshi S; Anstey KM
    Allergy Asthma Proc; 2022 Sep; 43(5):431-434. PubMed ID: 36065101
    [No Abstract]   [Full Text] [Related]  

  • 91. The adverse reactions to vaccines practice parameter 10 years on-what have we learned?
    Kelso JM
    Ann Allergy Asthma Immunol; 2022 Jul; 129(1):35-39. PubMed ID: 35101646
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital.
    Paoletti G; Pepys J; Bragato MC; Paoletti S; Piona A; Messina MR; Racca F; Ferri S; Nappi E; Costanzo G; Del Moro L; Puggioni F; Canonica GW; Azzolini E; Heffler E
    Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37243007
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Risk of anaphylaxis after vaccination in children and adults.
    McNeil MM; Weintraub ES; Duffy J; Sukumaran L; Jacobsen SJ; Klein NP; Hambidge SJ; Lee GM; Jackson LA; Irving SA; King JP; Kharbanda EO; Bednarczyk RA; DeStefano F
    J Allergy Clin Immunol; 2016 Mar; 137(3):868-78. PubMed ID: 26452420
    [TBL] [Abstract][Full Text] [Related]  

  • 94. COVID-19 mRNA vaccine allergy.
    Risma KA
    Curr Opin Pediatr; 2021 Dec; 33(6):610-617. PubMed ID: 34670264
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pfizer/BioNTech SARS-CoV-2 vaccine as a potential trigger for the development of narcolepsy: a case report.
    Mahamid A; Bornstein RJ; Amir H
    J Clin Sleep Med; 2022 Oct; 18(10):2503-2506. PubMed ID: 35733336
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Israel's rapid rollout of vaccinations for COVID-19.
    Rosen B; Waitzberg R; Israeli A
    Isr J Health Policy Res; 2021 Jan; 10(1):6. PubMed ID: 33499905
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study.
    Ogar CK; Quick J; Gilbert HN; Vreman RA; Mantel-Teeuwisse AK; Mugunga JC
    Drug Saf; 2023 Apr; 46(4):357-370. PubMed ID: 36811813
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Acute unsolicited adverse events following BNT162b2 vaccine in Saudi Arabia, a real-world data.
    Almohaya AM; Alsubie H; Alqarni B; Alzayad B; Alghar A; Alshahrani K; Barry M
    Vaccine; 2022 Jan; 40(3):477-482. PubMed ID: 34916104
    [TBL] [Abstract][Full Text] [Related]  

  • 99. SARS-CoV-2 and allergy - what have we learned after two and a half years?
    Brockow K; Wang R; Mathes S; Bent R; Faihs V; Eberlein B; Darsow U; Biedermann T
    Allergol Select; 2023; 7():101-112. PubMed ID: 37056446
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Prolonged angioedema after Pfizer-BioNTech COVID-19 vaccine.
    Muhamad Fauzi SM
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36882264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.